Analyzing SBC Medical Group (NASDAQ:SBC) and Solventum (NYSE:SOLV)

SBC Medical Group (NASDAQ:SBC) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.

Institutional and Insider Ownership

60.8% of SBC Medical Group shares are owned by institutional investors. 89.5% of SBC Medical Group shares are owned by insiders. Comparatively, 0.2% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares SBC Medical Group and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	29.37%	20.76%	15.67%
Solventum	18.69%	25.26%	7.40%

Risk & Volatility

SBC Medical Group has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Solventum has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for SBC Medical Group and Solventum, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1	0	2	0	2.33
Solventum	1	5	7	0	2.46

SBC Medical Group currently has a consensus price target of $8.50, indicating a potential upside of 150.00%. Solventum has a consensus price target of $90.09, indicating a potential upside of 30.57%. Given SBC Medical Group’s higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Solventum.

Valuation and Earnings

This table compares SBC Medical Group and Solventum”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61 million	2.01	$50.99 million	$0.49	6.94
Solventum	$8.33 billion	1.44	$1.56 billion	$8.87	7.78

Solventum has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.